Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMID 18806710)

Published in Pediatr Endocrinol Rev on August 01, 2008

Authors

Julia M Steinke1, Michael Mauer, International Diabetic Nephropathy Study Group

Author Affiliations

1: Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota 55455, USA.

Associated clinical trials:

Renal Resisitive Index as an Indicator of the Progression of Diabetic Nephropathy | NCT03658317

Articles by these authors

Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis (2010) 3.87

Glomerular cell number in normal subjects and in type 1 diabetic patients. Kidney Int (2001) 2.73

Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: an indicator of more advanced glomerular lesions. Diabetes (2003) 2.16

Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type 1 diabetic nephropathy. Diabetes (2007) 2.08

An increase in the cell component of the cortical interstitium antedates interstitial fibrosis in type 1 diabetic patients. Kidney Int (2002) 1.80

The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes. Diabetes (2002) 1.79

Angiotensin II blockade in kidney transplant recipients. J Am Soc Nephrol (2013) 1.77

Cellular basis of diabetic nephropathy: 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes. Diabetes (2002) 1.70

The early natural history of nephropathy in Type 1 Diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients. Diabetes (2005) 1.67

Histopathology of diabetic nephropathy. Semin Nephrol (2007) 1.60

The relationship of diabetic retinopathy to preclinical diabetic glomerulopathy lesions in type 1 diabetic patients: the Renin-Angiotensin System Study. Diabetes (2005) 1.40

Podocyte structural parameters do not predict progression to diabetic nephropathy in normoalbuminuric type 1 diabetic patients. Am J Nephrol (2015) 1.39

Susceptibility to diabetic nephropathy is related to dicarbonyl and oxidative stress. Diabetes (2005) 1.34

Progressive podocyte injury and globotriaosylceramide (GL-3) accumulation in young patients with Fabry disease. Kidney Int (2010) 1.25

Prognostic indicators of renal disease progression in adults with Fabry disease: natural history data from the Fabry Registry. Clin J Am Soc Nephrol (2010) 1.24

Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiation. Nephrol Dial Transplant (2011) 1.23

Atubular glomeruli and glomerulotubular junction abnormalities in diabetic nephropathy. J Am Soc Nephrol (2003) 1.21

Proposed pathogenesis of idiopathic loin pain-hematuria syndrome. Am J Kidney Dis (2006) 1.18

Diabetes and nephropathy. Curr Opin Nephrol Hypertens (2003) 1.16

Glomerulotubular junction abnormalities are associated with proteinuria in type 1 diabetes. J Am Soc Nephrol (2006) 1.16

Enhancing the predictive value of urinary albumin for diabetic nephropathy. J Am Soc Nephrol (2006) 1.14

Uric acid lowering to prevent kidney function loss in diabetes: the preventing early renal function loss (PERL) allopurinol study. Curr Diab Rep (2013) 1.09

GFR-estimating models in kidney transplant recipients on a steroid-free regimen. Nephrol Dial Transplant (2010) 1.04

Comparison of methods for counting cells in the mouse glomerulus. Nephron Exp Nephrol (2006) 1.03

Renal lesions predict progression of diabetic nephropathy in type 1 diabetes. J Am Soc Nephrol (2013) 1.01

Diabetic nephropathy: diabetic nephropathy-challenges in pathologic classification. Nat Rev Nephrol (2010) 1.01

Cellular basis of diabetic nephropathy: II. The transforming growth factor-beta system and diabetic nephropathy lesions in type 1 diabetes. Diabetes (2002) 1.00

Effects of duration and age at onset of type 1 diabetes on preclinical manifestations of nephropathy. Diabetes (2003) 0.99

Fabry disease: dose matters. J Am Soc Nephrol (2014) 0.97

Albumin excretion rate in normal adolescents: relation to insulin resistance and cardiovascular risk factors and comparisons to type 1 diabetes mellitus patients. Clin J Am Soc Nephrol (2008) 0.96

The relation of ambulatory blood pressure and pulse rate to retinopathy in type 1 diabetes mellitus: the renin-angiotensin system study. Ophthalmology (2006) 0.96

Renal complications of Fabry disease in children. Pediatr Nephrol (2012) 0.93

Diabetic nephropathy is associated with gene expression levels of oxidative phosphorylation and related pathways. Diabetes (2006) 0.92

Early progression of diabetic nephropathy correlates with methylglyoxal-derived advanced glycation end products. Diabetes Care (2013) 0.90

Progression of diabetic nephropathy in type 1 diabetic patients. Diabetes Res Clin Pract (2008) 0.89

Gene expression differences in skin fibroblasts in identical twins discordant for type 1 diabetes. Diabetes (2012) 0.89

Assessment of renal pathology and dysfunction in children with Fabry disease. Clin J Am Soc Nephrol (2010) 0.84

Having one kidney does not accelerate the rate of development of diabetic nephropathy lesions in type 1 diabetic patients. Diabetes (2008) 0.83

Normoalbuminuric diabetic kidney disease in the U.S. population. J Diabetes Complications (2012) 0.83

Estimating mean glomerular volume using two arbitrary parallel sections. J Am Soc Nephrol (2002) 0.83

Temporal profile of diabetic nephropathy pathologic changes. Curr Diab Rep (2013) 0.83

Reversal of diabetic nephropathy: lessons from pancreas transplantation. J Nephrol (2012) 0.81

Glomerular structure in the normal human kidney: differences between living and cadaver donors. J Am Soc Nephrol (2003) 0.81

Morphologic features of declining renal function in type 1 diabetes. Semin Nephrol (2012) 0.81

Benefits of Renin-Angiotensin blockade on retinopathy in type 1 diabetes vary with glycemic control. Diabetes Care (2011) 0.81

Cellular basis of diabetic nephropathy: IV. Antioxidant enzyme mRNA expression levels in skin fibroblasts of type 1 diabetic sibling pairs. Nephrol Dial Transplant (2006) 0.80

Effects of pancreas transplantation on the prevention and reversal of diabetic nephropathy. Contrib Nephrol (2011) 0.80

Urinary albumin as an indicator of diabetic nephropathy lesions in Japanese type 2 diabetic patients. Nephron (2002) 0.80

Glomerular structural factors in progression of congenital nephrotic syndrome. Pediatr Nephrol (2003) 0.80

Relationship of blood pressure to retinal vessel diameter in type 1 diabetes mellitus. Arch Ophthalmol (2010) 0.79

Tacrolimus and cyclosporine nephrotoxicity in native kidneys of pancreas transplant recipients. Clin J Am Soc Nephrol (2010) 0.79

Cat-scratch disease relapse in a kidney transplant recipient. Pediatr Transplant (2007) 0.79

Detection of diabetic nephropathy from advanced glycation endproducts (AGEs) differs in plasma and urine, and is dependent on the method of preparation. Amino Acids (2013) 0.79

Comparing the automated versus manual method of needle biopsy for renal histology artefacts. Nephrol Dial Transplant (2008) 0.78

Quantitating glomerular endothelial fenestration: an unbiased stereological approach. Am J Nephrol (2011) 0.78

Enalapril accelerates remodeling of the renal interstitium after release of unilateral ureteral obstruction in rats. J Nephrol (2003) 0.78

Angiotensin II receptor blocker pretreatment of rats undergoing sudden renal ablation. Nephrol Dial Transplant (2011) 0.77

Effect of angiotensin II on glomerular structure in streptozotocin-induced diabetic rats. Am J Nephrol (2004) 0.77

Angiotensin II receptor blockade blocker pre-treatment largely prevents injury from gradual renal ablation in rats. J Renin Angiotensin Aldosterone Syst (2007) 0.76

Cellular basis of diabetic nephropathy: V. Endoglin expression levels and diabetic nephropathy risk in patients with Type 1 diabetes. J Diabetes Complications (2009) 0.76

Olmesartan, microalbuminuria, and type 2 diabetes. N Engl J Med (2011) 0.75

Albuminuria according to status of autoimmunity and insulin sensitivity among youth with type 1 and type 2 diabetes. Diabetes Care (2013) 0.75

Adherence and renal biopsy feasibility in the Renin Angiotensin-System Study (RASS) primary prevention diabetes trial. Diabetes Res Clin Pract (2013) 0.75

Preventing microalbuminuria in type 2 diabetes. N Engl J Med (2005) 0.75

Glomerulopathy in spontaneously obese rhesus monkeys with type 2 diabetes: a stereological study. Diabetes Metab Res Rev (2011) 0.75

Microalbuminuria in patients with cystic fibrosis. Diabetes Care (2011) 0.75

Predilection of segmental glomerulosclerosis lesions for the glomerulotubular junction area in type 1 diabetic patients: a novel mapping method. PLoS One (2013) 0.75

Erratum. Nephrol Dial Transplant (2017) 0.75

Idiopathic intracranial hypertension immediately after kidney transplantation in a pediatric recipient. Pediatr Nephrol (2004) 0.75

Lactic acidosis and hypoglycemia with ALL relapse following engrafted bone marrow transplant. Pediatr Blood Cancer (2009) 0.75

A re-evaluation of the renal ablation model of progressive renal disease in rats. J Nephrol (2003) 0.75